JP2018510131A5 - - Google Patents

Download PDF

Info

Publication number
JP2018510131A5
JP2018510131A5 JP2017539457A JP2017539457A JP2018510131A5 JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5 JP 2017539457 A JP2017539457 A JP 2017539457A JP 2017539457 A JP2017539457 A JP 2017539457A JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
active metabolite
pharmaceutically
och
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2017539457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018510131A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/050477 external-priority patent/WO2016120850A1/en
Publication of JP2018510131A publication Critical patent/JP2018510131A/ja
Publication of JP2018510131A5 publication Critical patent/JP2018510131A5/ja
Ceased legal-status Critical Current

Links

JP2017539457A 2015-01-30 2016-01-29 Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法 Ceased JP2018510131A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562110060P 2015-01-30 2015-01-30
US62/110,060 2015-01-30
US201562267350P 2015-12-15 2015-12-15
US62/267,350 2015-12-15
PCT/IB2016/050477 WO2016120850A1 (en) 2015-01-30 2016-01-29 Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2018510131A JP2018510131A (ja) 2018-04-12
JP2018510131A5 true JP2018510131A5 (https=) 2019-06-20

Family

ID=55405379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017539457A Ceased JP2018510131A (ja) 2015-01-30 2016-01-29 Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法

Country Status (5)

Country Link
US (1) US10385036B2 (https=)
EP (1) EP3250561A1 (https=)
JP (1) JP2018510131A (https=)
CA (1) CA2975157C (https=)
WO (1) WO2016120850A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10336748B2 (en) 2015-01-30 2019-07-02 Pfizer Inc. Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
KR102037494B1 (ko) 2017-12-11 2019-10-28 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
KR20190120112A (ko) 2019-10-08 2019-10-23 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
CN115322105A (zh) * 2021-05-11 2022-11-11 江苏润安制药有限公司 一种合成艾拉莫德关键中间体的方法
CN116135839A (zh) * 2021-11-18 2023-05-19 江苏润安制药有限公司 一种阿齐沙坦关键中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742057A (en) 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
GB9211276D0 (en) * 1992-05-28 1992-07-15 Glaxo Lab Sa Pharmaceutical compositions
US5962473A (en) 1996-08-16 1999-10-05 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
WO1999007700A1 (en) 1997-08-09 1999-02-18 Smithkline Beecham Plc Bicyclic compounds as ligands for 5-ht1 receptors
EP1083918A1 (en) 1998-06-08 2001-03-21 Advanced Medicine, Inc. Novel therapeutic agents that modulate 5-ht receptors
ATE340795T1 (de) * 2001-01-30 2006-10-15 Lilly Co Eli Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
WO2013007582A2 (en) 2011-07-08 2013-01-17 Syngenta Participations Ag Processes for the preparation of thietanamine
WO2014026328A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026330A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
LT3027603T (lt) 2013-08-02 2018-08-10 Pfizer Inc. Heterobicikloarilo rorc2 inhibitoriai ir jų panaudojimo būdai
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
US10336748B2 (en) 2015-01-30 2019-07-02 Pfizer Inc. Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2018510131A5 (https=)
JP2013525433A5 (https=)
HRP20210745T1 (hr) Supstituirani spojevi tetrahidrokinolinona kao ror gama modulatori
RU2013144579A (ru) Ингибиторы киназы mst1 и способы их применения
JP2014505033A5 (https=)
CA2797663A1 (en) Compounds that modulate intracellular calcium
JP2013523802A5 (https=)
JP2019518071A5 (https=)
JP2016500661A5 (https=)
JP2011016800A5 (https=)
JP2015535277A5 (https=)
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
JP2013533884A5 (https=)
RU2017134551A (ru) Новые дигидропиридоизохинолиноны и их фармацевтические композиции для лечения воспалительных расстройств
JP2019514874A5 (https=)
RU2015137756A (ru) Макроциклические производные пиридазинона
CA2797533A1 (en) Compounds that modulate intracellular calcium
JP2004529874A5 (https=)
HRP20200016T1 (hr) Amidno supstituirani tiazoli kao modulatori rorgamat
JP2015062072A5 (https=)
RU2010143907A (ru) Твердые формы, содержащие (+)-2-[1-(3-этокси-4-метоксифенил)-2-метилсульфонилэтил]-4-ацетиламиноизоиндолин-1, 3-дион, их композиции и применение
JP2012502111A5 (https=)
RU2008140943A (ru) Аналоги тиазолидиндиона
RU2016129380A (ru) Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
JP2013530238A5 (https=)